ARCHIVES

Newell, Fredrickson Question Ethics Of Laetrile Trials

This article is from The Cancer Letter archive.

Vol. 03 No. 29 | July 22, 1977

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

NCI Clarifies P01 Grant Application Dates

September 13, 1996

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Giaccone Joins Georgetown Lombardi Center

February 22, 2013

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009